Role of adrenal imaging in surgical management

Lamk M. Lamki, Thomas P. Haynie

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Adrenal imaging using radiopharmaceuticals is a functional test that can contribute significantly to surgical management and follow‐up of patients with either benign or malignant conditions of the adrenal cortex and medulla. Imaging of the cortex is achieved by iodine‐131‐labeled iodomethyl nor‐cholesterol (NP‐59), while adrenal medulla imaging can be successfully accomplished by 131I‐metaiodobenzylguanidine (MIBG), which localizes in the adrenergic nerve terminal with norepinephrine. Both tests carry high sensitivity and specificity for functional tumors and hyperplasia, and often better than CT scanning. This article reviews the current status and clinical utility of nuclear imaging of the adrenal cortex in congenital hyperplasia, low renin hypertension and aldosteronism, and Cushing's syndrome. Adrenal medulla imaging is reviewed in light of our experience at the University of Texas M.D. Anderson Cancer Center in pheochromocytoma, neuroblastoma, and other neuroectodermal tumors. Investigation of 131I‐MIBG therapy of metastatic tumors of neuroectodermal origin potentially offers a means of at least controlling symptoms of hormonal secretion in these patients.

Original languageEnglish
Pages (from-to)139-147
Number of pages9
JournalJournal of Surgical Oncology
Volume43
Issue number3
DOIs
Publication statusPublished - 1990

Fingerprint

Adrenal Medulla
Neuroectodermal Tumors
Adrenal Cortex
Hyperplasia
3-Iodobenzylguanidine
Hyperaldosteronism
Radiopharmaceuticals
Cushing Syndrome
Pheochromocytoma
Neuroblastoma
Renin
Adrenergic Agents
Neoplasms
Norepinephrine
Hypertension
Sensitivity and Specificity
Therapeutics

Keywords

  • adrenal cortex imaging
  • adrenal medulla imaging
  • adrenal scintigraphy
  • iodocholesterol scan (NP‐59)
  • meta‐iodobenzylguanidine (MIBG)
  • nuclear scintiscan—adrenal

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Role of adrenal imaging in surgical management. / Lamki, Lamk M.; Haynie, Thomas P.

In: Journal of Surgical Oncology, Vol. 43, No. 3, 1990, p. 139-147.

Research output: Contribution to journalArticle

Lamki, Lamk M. ; Haynie, Thomas P. / Role of adrenal imaging in surgical management. In: Journal of Surgical Oncology. 1990 ; Vol. 43, No. 3. pp. 139-147.
@article{3bcfb5f2c7dc4b94b9de102b7f23344b,
title = "Role of adrenal imaging in surgical management",
abstract = "Adrenal imaging using radiopharmaceuticals is a functional test that can contribute significantly to surgical management and follow‐up of patients with either benign or malignant conditions of the adrenal cortex and medulla. Imaging of the cortex is achieved by iodine‐131‐labeled iodomethyl nor‐cholesterol (NP‐59), while adrenal medulla imaging can be successfully accomplished by 131I‐metaiodobenzylguanidine (MIBG), which localizes in the adrenergic nerve terminal with norepinephrine. Both tests carry high sensitivity and specificity for functional tumors and hyperplasia, and often better than CT scanning. This article reviews the current status and clinical utility of nuclear imaging of the adrenal cortex in congenital hyperplasia, low renin hypertension and aldosteronism, and Cushing's syndrome. Adrenal medulla imaging is reviewed in light of our experience at the University of Texas M.D. Anderson Cancer Center in pheochromocytoma, neuroblastoma, and other neuroectodermal tumors. Investigation of 131I‐MIBG therapy of metastatic tumors of neuroectodermal origin potentially offers a means of at least controlling symptoms of hormonal secretion in these patients.",
keywords = "adrenal cortex imaging, adrenal medulla imaging, adrenal scintigraphy, iodocholesterol scan (NP‐59), meta‐iodobenzylguanidine (MIBG), nuclear scintiscan—adrenal",
author = "Lamki, {Lamk M.} and Haynie, {Thomas P.}",
year = "1990",
doi = "10.1002/jso.2930430304",
language = "English",
volume = "43",
pages = "139--147",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Role of adrenal imaging in surgical management

AU - Lamki, Lamk M.

AU - Haynie, Thomas P.

PY - 1990

Y1 - 1990

N2 - Adrenal imaging using radiopharmaceuticals is a functional test that can contribute significantly to surgical management and follow‐up of patients with either benign or malignant conditions of the adrenal cortex and medulla. Imaging of the cortex is achieved by iodine‐131‐labeled iodomethyl nor‐cholesterol (NP‐59), while adrenal medulla imaging can be successfully accomplished by 131I‐metaiodobenzylguanidine (MIBG), which localizes in the adrenergic nerve terminal with norepinephrine. Both tests carry high sensitivity and specificity for functional tumors and hyperplasia, and often better than CT scanning. This article reviews the current status and clinical utility of nuclear imaging of the adrenal cortex in congenital hyperplasia, low renin hypertension and aldosteronism, and Cushing's syndrome. Adrenal medulla imaging is reviewed in light of our experience at the University of Texas M.D. Anderson Cancer Center in pheochromocytoma, neuroblastoma, and other neuroectodermal tumors. Investigation of 131I‐MIBG therapy of metastatic tumors of neuroectodermal origin potentially offers a means of at least controlling symptoms of hormonal secretion in these patients.

AB - Adrenal imaging using radiopharmaceuticals is a functional test that can contribute significantly to surgical management and follow‐up of patients with either benign or malignant conditions of the adrenal cortex and medulla. Imaging of the cortex is achieved by iodine‐131‐labeled iodomethyl nor‐cholesterol (NP‐59), while adrenal medulla imaging can be successfully accomplished by 131I‐metaiodobenzylguanidine (MIBG), which localizes in the adrenergic nerve terminal with norepinephrine. Both tests carry high sensitivity and specificity for functional tumors and hyperplasia, and often better than CT scanning. This article reviews the current status and clinical utility of nuclear imaging of the adrenal cortex in congenital hyperplasia, low renin hypertension and aldosteronism, and Cushing's syndrome. Adrenal medulla imaging is reviewed in light of our experience at the University of Texas M.D. Anderson Cancer Center in pheochromocytoma, neuroblastoma, and other neuroectodermal tumors. Investigation of 131I‐MIBG therapy of metastatic tumors of neuroectodermal origin potentially offers a means of at least controlling symptoms of hormonal secretion in these patients.

KW - adrenal cortex imaging

KW - adrenal medulla imaging

KW - adrenal scintigraphy

KW - iodocholesterol scan (NP‐59)

KW - meta‐iodobenzylguanidine (MIBG)

KW - nuclear scintiscan—adrenal

UR - http://www.scopus.com/inward/record.url?scp=0025213180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025213180&partnerID=8YFLogxK

U2 - 10.1002/jso.2930430304

DO - 10.1002/jso.2930430304

M3 - Article

VL - 43

SP - 139

EP - 147

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -